The melanocytic gene set is driven by the transcription factor MITF, which enhanced the levels of the tumor suppressor and translation inhibitor REDD2 in the TTD melanoma cells, where it antagonized proliferation. This evidence concerns the gene DDIT4L and neoplasm.